infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 2,090 articles

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Access to medicines & diagnostics

    Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access

    Treatment Action Group / 04 November 2021

  • Hepatitis C elimination

    Australia: Sustained investment is needed to eliminate hepatitis C by 2030

    Burnet Institute / 04 November 2021

  • Greater NAFLD Severity Linked to Higher Cardiovascular Risk

    Hep Mag / 25 October 2021

  • Newsom signs bills to broaden STD testing, hepatitis screenings

    Bay Area Reporter / 25 October 2021

  • California Pioneers Mandatory Testing for Hepatitis B and C

    KQED / 25 October 2021

  • Access to medicines & diagnostics

    Russia struggling with adequate access to hepatitis C drugs

    Pharma Letter / 25 October 2021

  • England: Fewer than 700 community pharmacies sign up to provide hepatitis C testing

    Pharmaceutical Journal / 20 September 2021

  • Treatment for people who use drugs

    Addressing the Intertwined Opioid, HIV, and HCV Crises: Q&A with Rick Altice

    Yale School of Medicine / 20 September 2021

  • Testing for hepatitis C

    Rapid hepatitis C testing to be rolled out at dozens of sites nationwide

    Sydney Morning Herald / 20 September 2021

  • Testing for hepatitis C

    Can Hepatitis C Self-Testing Bring Us Closer to Eliminating the Virus?

    The BodyPro / 03 September 2021

← Prev12345...209Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//